These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38127682)

  • 21. Interventions, Barriers, and Proposed Solutions Associated With the Implementation of a Protocol That Uses Clinical Decision Support and a Stress Biomarker Test to Identify ICU Patients at High-Risk for Drug Associated Acute Kidney Injury.
    Williams VL; Smithburger PL; Imhoff AN; Groetzinger LM; Culley CM; Burke CX; Murugan R; Lamberty PE; Mahmud M; Benedict NJ; Kellum JA; Kane-Gill SL
    Ann Pharmacother; 2023 Apr; 57(4):408-415. PubMed ID: 35962583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perceived barriers to pharmacist engagement in adverse drug event prevention activities in Ghana using semi-structured interview.
    Acheampong F; Anto BP
    BMC Health Serv Res; 2015 Sep; 15():361. PubMed ID: 26345278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Utility of Urinary NGAL as an Alternative for Serum Creatinine to Detect Acute Kidney Injury in Infants Exposed to Nephrotoxic Medications in the Neonatal Intensive Care Unit.
    Stoops C; Gavigan H; Krallman K; Anderson N; Griffin R; Slagle C; House S; Goldstein SL; Askenazi DJ
    Neonatology; 2024; 121(2):203-212. PubMed ID: 38151013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
    Aghili M; Neelathahalli Kasturirangan M
    JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of pharmacist-led medication management in care transitions.
    Yang S
    BMC Health Serv Res; 2017 Nov; 17(1):722. PubMed ID: 29132369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of emergency department pharmacists on drug overuse and drug underuse in patients with an ADE-related hospitalisation: a controlled intervention study.
    Rahman RN; Nikolik B; de Ridder MAJ; Hoek AE; Janssen MJA; Schuit SCE; Karapinar-Çarkit F; van den Bemt PMLA
    BMC Health Serv Res; 2022 Nov; 22(1):1363. PubMed ID: 36397102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacist-Driven Geriatric Medication Assessment at an Acute Care Teaching Hospital.
    Steele AJ; Berletic JD; Gionfriddo MR
    Sr Care Pharm; 2023 May; 38(5):179-184. PubMed ID: 37185144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacist-led medication reviews in pre-dialysis and dialysis patients.
    van Berlo-van de Laar IRF; Sluiter HE; Riet EV'; Taxis K; Jansman FGA
    Res Social Adm Pharm; 2020 Dec; 16(12):1718-1723. PubMed ID: 32111533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrotoxin Exposure and Acute Kidney Injury in Adults.
    Griffin BR; Wendt L; Vaughan-Sarrazin M; Hounkponou H; Reisinger HS; Goldstein SL; Jalal D; Misurac J
    Clin J Am Soc Nephrol; 2023 Feb; 18(2):163-172. PubMed ID: 36754005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intervention of pharmacist included in multidisciplinary team to reduce adverse drug event: a qualitative systematic review.
    Zaij S; Pereira Maia K; Leguelinel-Blache G; Roux-Marson C; Kinowski JM; Richard H
    BMC Health Serv Res; 2023 Aug; 23(1):927. PubMed ID: 37649018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electronic health record identification of nephrotoxin exposure and associated acute kidney injury.
    Goldstein SL; Kirkendall E; Nguyen H; Schaffzin JK; Bucuvalas J; Bracke T; Seid M; Ashby M; Foertmeyer N; Brunner L; Lesko A; Barclay C; Lannon C; Muething S
    Pediatrics; 2013 Sep; 132(3):e756-67. PubMed ID: 23940245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic Outcomes Associated with Safety Interventions by a Pharmacist-Adjudicated Prior Authorization Consult Service.
    Jacob S; Britt RB; Bryan WE; Hashem MG; Hale JC; Brown JN
    J Manag Care Spec Pharm; 2019 Mar; 25(3):411-416. PubMed ID: 30816815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
    Leape LL; Cullen DJ; Clapp MD; Burdick E; Demonaco HJ; Erickson JI; Bates DW
    JAMA; 1999 Jul; 282(3):267-70. PubMed ID: 10422996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of providing psychiatry specialty pharmacist intervention on reducing drug-related problems among children with autism spectrum disorder related to disruptive behavioural symptoms: A prospective randomized open-label study.
    Wongpakaran R; Suansanae T; Tan-Khum T; Kraivichian C; Ongarjsakulman R; Suthisisang C
    J Clin Pharm Ther; 2017 Jun; 42(3):329-336. PubMed ID: 28317138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Handling drug-related problems in rehabilitation patients: a randomized study.
    Willoch K; Blix HS; Pedersen-Bjergaard AM; Eek AK; Reikvam A
    Int J Clin Pharm; 2012 Apr; 34(2):382-8. PubMed ID: 22388601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of pharmacist practice of medication therapy management in ambulatory care: an experience from a comprehensive Chinese hospital.
    Meng Q; Sun L; Ma Y; Wei Y; Ma X; Yang L; Xie Z; Li F; Wang Z; Tao X; Zhen X; Jin R; Gu H
    BMC Health Serv Res; 2023 Feb; 23(1):176. PubMed ID: 36810022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the impact of telepharmacy.
    Schneider PJ
    Am J Health Syst Pharm; 2013 Dec; 70(23):2130-5. PubMed ID: 24249763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the implementation of a clinical pharmacy service on an acute internal medicine ward in Italy.
    Lombardi N; Wei L; Ghaleb M; Pasut E; Leschiutta S; Rossi P; Troncon MG
    BMC Health Serv Res; 2018 Apr; 18(1):259. PubMed ID: 29631587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying High-Risk Medications Associated with Acute Kidney Injury in Critically Ill Patients: A Pharmacoepidemiologic Evaluation.
    Slater MB; Gruneir A; Rochon PA; Howard AW; Koren G; Parshuram CS
    Paediatr Drugs; 2017 Feb; 19(1):59-67. PubMed ID: 27943125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephrotoxicities.
    Goldstein SL
    F1000Res; 2017; 6():55. PubMed ID: 28163909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.